Iberia Pharmaceuticals India Ltd IPO
Pre Issue Shares
1,94,26,770
No. of Shares Issued
64,75,560
Pre Issue Equity Amt.
₹19.43 Cr
DP Filling Date
September 5, 2026
Iberia Pharmaceuticals India Ltd IPO Timeline
| Event | Date |
|---|---|
| Iberia Pharmaceuticals India Ltd IPO Opening Date | - |
| Iberia Pharmaceuticals India Ltd IPO Closing Date | - |
| Basis of Allotment | - |
| Initiation of Refunds | - |
| Credit of Shares to Demat | - |
| Iberia Pharmaceuticals India Ltd IPO Listing Date | - |
Iberia Pharmaceuticals India Ltd IPO Details
| Iberia Pharmaceuticals India Ltd IPO Date | - |
| Iberia Pharmaceuticals India Ltd IPO Face Value | - |
| Iberia Pharmaceuticals India Ltd IPO Price | - |
| Iberia Pharmaceuticals India Ltd IPO Lot Size | - |
| Issue Size | - |
| Fresh Issue | - |
| Offer for Sale | - |
| Issue Type | - |
| Listing At | - |
| QIB Shares Offered | - |
| Retail Shares Offered | - |
| NII (HNI) Shares Offered | - |
| Company Promoters | Nitin Jain, Rishabh Jain, Saurav Ojha |
- Strengths
- Risks
- Opportunities
- Pan-India player with leadership position in West and Central India.
- Diversified and expanding product portfolio with innovative offerings.
- Established and scalable distribution network.
- Robust sourcing capabilities and strategically located manufacturing facilities.
- Strong liquidity position with a track record of consistent financial performance.
- Experienced Promoters and senior management team, backed by marquee investors.
Objects of the Issue
The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
- Capital expenditure towards the procurement of plant & machinery for the establishment of the manufacturing facility in Haryana, India.
- Repayment of all or a portion of certain outstanding borrowings availed by the Company.
- Branding and marketing expenses towards enhancing the awareness and visibility of the products and brand.
- Funding the working capital requirements of the Company.
- General Corporate Purposes.
Iberia Pharmaceuticals India Ltd IPO Prospectus
Iberia Pharmaceuticals India Ltd IPO Listing Date
| BSE Script | |
| NSE Symbol | |
| Listing In | - |
| IPO Price | ₹- |
| Face Value | ₹- |
Company Contact Information
No.4 Block-C 1st Flr Sector-8Dwarka Bagdola South WestDelhi,New Delhi-110077
Phone: +91 93197 28265
Email: cs@iberiapharmaceuticals.com
Website: www.iberiapharmaceuticals.com
Iberia Pharmaceuticals India Ltd IPO Registrar
Iberia Pharmaceuticals India Ltd IPO Lead Manager(s)
- Turnaround Corporate Advisors Pvt Ltd
How to Check the Allotment Status of Iberia Pharmaceuticals India Ltd IPO?
To check the IPO allotment status, follow these steps:
- Visit the official website of the IPO registrar.
- Navigate to the IPO Allotment Status page.
- Select “Iberia Pharmaceuticals India Ltd” from the list of available IPOs.
- Enter any one of these - PAN Number, Application Number, DP/Client ID.
- Click on Submit to view your allotment status.
About Iberia Pharmaceuticals India Ltd IPO
Iberia Pharmaceuticals India Limited was originally incorporated as Satnam Medical Agencies Private Limited' as a private limited company under Companies Act, 1956, dated March 30, 2013, with the Registrar of Companies, Delhi and Haryana. Subsequently, the name of the Company was changed to Iberia Pharmaceuticals India Private Limited' dated September 18, 2023. Thereafter, it was converted into a Public Limited Company and a fresh certificate of Incorporation dated July 15, 2024 was issued by the Central Processing Centre.

